This site uses cookies. By using it you agree to their use in accordance with current browser settings .
I accept

Loading...


Search Menu
A A A high contrast A A

Export Promotion Portal



Polish pharma sector at CPhI China 2019

Wyślij Print Pobierz added: Anna Woińska | 2019-06-18 11:10:17
shanghai, china, cphi china, 2019, polish national stand, pharma sector, polish companies, polish investment and trade agency, paih, promotion program for biotechnology and pharmaceutical industry

Polish Investment & Trade Agency organizes a Polish Stand during 2019 edition of CPhI China in Shanghai as a part of the Promotion Program, aiming to increase awareness and promote selected branches of Polish economy abroad. /English & Chinese version/

SCROLL DOWN FOR CHINESE VERSION

CPhIChina

- For the second consecutive year, Poland will actively participate in the largest pharma trade event in China. Our pharma and life science companies are becoming more export-oriented and we are happy to help them in exploring new opportunities in Asia’s largest market - says Dr Andrzej Juchniewicz, Shanghai Bureau Chief of the Polish Investment and Trade Agency.

 

In adittion to Polish national stand, following polish companies representing biotech and pharma sectors will also take part in the event in Shanghai:

  • Polpharma - the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. It actively operates in the markets of Central and Eastern Europe, the Caucasus and Central Asia. Company has 7 manufacturing plants in Poland, Russia and Kazakhstan, and 7 research and development centres. Manufacturer of a wide range of prescription drugs and pharmaceuticals for in-patient care.
  • Greenvit - a botanical extract manufacturer from Poland, established in 2010. Greenvit’s mission is to improve the overall quality of natural ingredients used by pharmaceutical and food manufacturers worldwide by implementing innovative projects related to production of natural and pro-health products.

 

Poland is a booming country among Central & Eastern Europe (CEE) members of the EU and prospects for biotech/pharma industries reflect that position. According to research and consulting firm GlobalData: the Polish pharmaceutical industry is set to rise from $9.4 billion in 2016 to around $11 billion by 2021.

 

According to latest data, more than 200 companies carried out activities in biotechnology field in Poland employing almost 9000 people. Main trends include:

  • Biosimilars
  • New, innovative drugs based on small molecules
  • Large scale production of advanced generic drugs.

 

Poland’s pharmaceutical market is the largest in Central Europe and the 6th largest in the EU, employing more than 130 thousand people in 200+ companies.

 

Main competitive advantage of Polish biotech/pharma industries are widely perceived to be advanced versions of generic drugs and competitive prices.

 

Polish industry takes a lot of its strength from close cooperation with well-established educational clusters traditionally providing much needed highly skilled university postgraduates.

 

Main biotech/pharma clusters and companies are located in the following cities: Gdynia, Warsaw, Poznan, Lodz, Wroclaw, and Cracow.

 

CPhI China will be held on June 18-20, 2019 in Shanghai (Shanghai New International Expo Center). As a part of the event the press briefing will be held on June 19 at the stand run by Polish Investment and Trade Agency.

 

Source: Polish Investment and Trade Agency (www.paih.gov.pl)

 

Poland at CPhl China 2019

 

波兰投资贸易局参展 CPhI China 2019

作为推广计划的一部分,波兰投资贸易局将在2019年CPhI中国上海展会期间组织波兰展台,旨在提高波兰经济在海外的知名度,并推广波兰经济的部分分支机构。

 

波兰将连续第二年积极参与中国规模最大的医药贸易盛会。我们的制药和生命科学公司正变得更加以出口为导向,我们很高兴帮助他们在亚洲最大的市场探索新的机遇,波兰投资贸易局上海办事处首席代表尤德良博士表示。
在波兰国家展台上,代表生物技术和制药行业的波兰公司也将参加上海的活动:

  • Polpharma - 波兰最大的制药企业,也是波兰医药市场的领导者。它积极在中欧和东欧、高加索和中亚市场开展业务。公司在波兰、俄罗斯和哈萨克斯坦设有7家制造厂和7个研发中心。生产多种处方药和住院病人护理药品。
  • Greenvit - 是一家来自波兰的植物提取物制造商,成立于2010年。Greenvit的使命是通过实施与生产天然和健康产品相关的创新项目,提高全球制药和食品制造商使用的天然成分的整体质量。

 

波兰是欧盟中东欧(CEE)成员国中蓬勃发展的国家,生物技术/制药行业的前景广阔。根据研究和咨询公司GlobalData的数据:到2021年,波兰制药业将从2016年的94亿美元增长到110亿美元左右。

 

根据最新数据,在波兰,有200多家公司,近9000人在从事生物技术领域的活动。主要趋势包括:

  • 生物仿制药
  • 基于小分子的新型创新药物
  • 大规模生产先进的仿制药。

 

波兰的医药市场是中欧最大的,也是欧盟第六大市场,拥有200多家公司,雇佣了13万多名员工。

 

波兰生物技术/制药行业的主要竞争优势是其先进的仿制药和具有竞争力的价格。
波兰工业通过与传统上提供急需的高技能大学研究生的完善教育集群的密切合作,充分发挥其力量。

 

主要的生物技术/制药集群和公司位于以下城市:格丁尼亚,华沙,波兹南,罗兹,弗罗茨瓦夫和克拉科夫。

 

CPhI中国将于2019年6月18日至20日在上海(上海新国际博览中心)举行。作为活动的一部分,波兰投资贸易局将于6月19日中午12时,在波兰国家展台举办媒体发布会,诚挚邀请媒体朋友和行业专家前来咨询交流。

 

资料来源:波兰投资贸易局 (www.paih.gov.pl)